MiRNA-based therapy for Cancer: MIRNA-134 increases the expression of tumor suppressor PTEN via down regulation of its target gene, 21/September/2014, 05.50 am

MiRNA-based therapy for Cancer: MIRNA-134 increases the expression of tumor suppressor PTEN via down regulation of its target gene, 21/September/2014, 05.50 am

MiRNA-based therapy for Cancer: MIRNA-134 increases the expression of tumor suppressor PTEN via down regulation of its target gene, 21/September/2014, 05.50 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNA-based therapy for Cancer: MIRNA-134 increases the expression of tumor suppressor PTEN via down regulation of its target gene, 21/September/2014, 05.50 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: PTEN is the second most mutated gene in human cancer.  MIRNA-134, by suppressing the expression of its target gene, it could induce the expression of PTEN.  Thus, pharmacological formulations encompassing MIRNA-134” can be used to treat PTEN-mutated human cancers. 

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation